Journal of Neuropathology & Experimental Neurology,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 20, 2025
Abstract
Chitinase
3-like
protein
1
(CHI3L1)
is
emerging
as
a
promising
biomarker
for
assessing
intracranial
lesion
burden
and
predicting
prognosis
in
traumatic
brain
injury
(TBI)
patients.
Following
experimental
TBI,
Chi3l1
transcripts
were
detected
reactive
astrocytes
located
within
the
pericontusional
cortex.
However,
cellular
sources
of
CHI3L1
response
to
hemorrhagic
contusions
human
remain
unidentified.
Hence,
we
examined
comprehensive
collection
histologically
defined
acute
subacute
cerebral
with
various
surgical
intervals
using
immunohistochemistry,
validated
through
double
immunofluorescence
markers
such
GFAP,
NeuN,
MBP,
Iba-1,
along
Fluoro-Jade
C
histofluorescence
staining.
was
found
at
meningeal
interfaces,
showing
significant
thickening
subpial
glial
plate.
Paradoxically,
CHI3L1-positive
identified
neuroanatomical
locations
distant
from
foci,
where
numerous
eosinophilic
ischemic
neurons
also
exhibited
immunoreactivity.
immunostaining
extended
into
white
matter
tracts
highlighted
phagocytic
or
activated
microglia
forms
after
delayed
decompressions.
Given
these
findings,
advise
against
astrogliosis
marker
due
its
expression
multiple
cell
types,
including
astrocytes,
neurons,
oligodendrocytes,
ependymocytes,
leptomeningeal
cells,
microglia,
blood
vessels.
This
non-selective
underscores
potential
elevation
patterns
biofluids
reflect
overall
extent.
Chitinase
3-like
1
(also
known
as
CHI3L1
or
YKL-40)is
a
mammalian
chitinase
that
has
no
enzymatic
activity,
but
the
ability
to
bind
chitin,
polymer
of
N-acetylglucosamine
(GlcNAc).
Chitin
is
component
fungi,
crustaceans,
arthropods
including
insects
and
mites,
parasites,
completely
absent
from
mammals,
humans
mice.
In
general,
chitin-containing
organisms
produce
protect
body
exogenous
pathogen
well
hostile
environments,
it
was
thought
similar
effect
in
mammals.
However,
recent
studies
have
revealed
plays
pro-inflammatory
role
by
inducing
anti-apoptotic
activity
epithelial
cells
macrophages.
Under
chronic
inflammatory
conditions
such
bowel
disease
obstructive
pulmonary
disease,
many
groups
already
confirmed
expression
significantly
induced
on
apical
side
cells,
activates
downstream
pathways
involved
inflammation
carcinogenesis.
this
review
article,
we
will
summarize
under
various
disorders
would
like
discuss
potential
roles
those
cell
types.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Март 14, 2024
SUMMARY
While
challenging,
identifying
individuals
displaying
resilience
to
Alzheimer’s
disease
(AD)
and
understanding
the
underlying
mechanism
holds
great
promise
for
development
of
new
therapeutic
interventions
effectively
treat
AD.
Down
syndrome
(DS),
or
trisomy
21,
is
most
common
genetic
cause
Interestingly,
some
people
with
DS,
despite
developing
AD
neuropathology,
show
cognitive
decline.
Furthermore,
DS
are
at
an
increased
risk
myeloid
leukemia
due
somatic
mutations
in
hematopoietic
cells.
Recent
studies
indicate
that
cells
may
lead
neurodegeneration.
Microglia,
derived
from
lineages,
play
a
central
role
etiology.
We
therefore
hypothesize
microglia
carrying
associated
impart
Using
CRISPR-Cas9
gene
editing,
we
introduce
21-linked
hotspot
CSF2RB
A455D
mutation
into
human
pluripotent
stem
cell
(hPSC)
lines
both
healthy
individuals.
Employing
hPSC-based
vitro
culture
vivo
chimeric
mouse
brain
models,
response
pathological
tau,
suppresses
microglial
type-1
interferon
signaling,
independent
21
background.
This
reduces
neuroinflammation
enhances
phagocytic
autophagic
functions,
thereby
ameliorating
senescent
dystrophic
phenotypes
microglia.
Moreover,
promotes
unique
subcluster
tissue
repair
properties.
Importantly,
provide
protection
neuronal
function,
such
as
neurogenesis
synaptic
plasticity
brains
where
largely
repopulate
hippocampus.
When
co-transplanted
same
brains,
phagocytize
replace
wildtype
following
tau
treatment.
Our
findings
suggest
hPSC-derived
could
be
employed
develop
effective
replacement
therapy
other
age-related
neurodegenerative
diseases,
even
without
need
deplete
endogenous
diseased
prior
transplantation.
Journal of Neuropathology & Experimental Neurology,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 20, 2025
Abstract
Chitinase
3-like
protein
1
(CHI3L1)
is
emerging
as
a
promising
biomarker
for
assessing
intracranial
lesion
burden
and
predicting
prognosis
in
traumatic
brain
injury
(TBI)
patients.
Following
experimental
TBI,
Chi3l1
transcripts
were
detected
reactive
astrocytes
located
within
the
pericontusional
cortex.
However,
cellular
sources
of
CHI3L1
response
to
hemorrhagic
contusions
human
remain
unidentified.
Hence,
we
examined
comprehensive
collection
histologically
defined
acute
subacute
cerebral
with
various
surgical
intervals
using
immunohistochemistry,
validated
through
double
immunofluorescence
markers
such
GFAP,
NeuN,
MBP,
Iba-1,
along
Fluoro-Jade
C
histofluorescence
staining.
was
found
at
meningeal
interfaces,
showing
significant
thickening
subpial
glial
plate.
Paradoxically,
CHI3L1-positive
identified
neuroanatomical
locations
distant
from
foci,
where
numerous
eosinophilic
ischemic
neurons
also
exhibited
immunoreactivity.
immunostaining
extended
into
white
matter
tracts
highlighted
phagocytic
or
activated
microglia
forms
after
delayed
decompressions.
Given
these
findings,
advise
against
astrogliosis
marker
due
its
expression
multiple
cell
types,
including
astrocytes,
neurons,
oligodendrocytes,
ependymocytes,
leptomeningeal
cells,
microglia,
blood
vessels.
This
non-selective
underscores
potential
elevation
patterns
biofluids
reflect
overall
extent.